People living with rare diseases are being offered two years’ free access to an AI-powered app that captures medical ...
The annual awards recognise excellence across 15 categories spanning innovation, manufacturing, sustainability and leadership ...
The results for litifilimab support the potential to achieve rapid and durable improvements in skin disease activity ...
Chiesi UK and Ireland has announced a new programme to help transform COPD diagnosis across the UK by providing NHS primary ...
In a recent interview with Pharma Exec, Elaine Ferguson, Global President of Inizio Medical, explores how pharma leadership ...
Explore how pharma can help patients and patient organisations prepare for meaningful involvement in EU HTA without shaping ...
As a cross-functional leader with experience managing pricing and access strategy across more than 60 markets, she is the ...
This builds on a recently announced clinical collaboration between AstraZeneca and Summit to advance cancer treatments ...
Shionogi & Co, headquartered in Osaka, Japan, has agreed to acquire IntraBio, a biopharmaceutical company developing and ...
Beam Therapeutics has appointed Eric Foster as Chief Commercial Officer (CCO). Foster will lead Beam’s commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results